Key indicators: single-crystal X-ray study; T = 93 K; mean (C-C) = 0.005 Å; disorder in solvent or counterion; R factor = 0.035; wR factor = 0.063; data-to-parameter ratio = 16.1.
Related literature
For the preparation of 3,5-dibromosalicylaldehyde, see: Elzbieta et al. (1964) . For a related structure, see: Bei et al. (2003) .
Experimental
Crystal data [Cu(C 20 H 10 Table 1 Selected bond lengths (Å ).
Table 2 Hydrogen-bond geometry (Å , ). (Table 2 ).
The title complex was synthesized in two stages. In the first stage, 3,5-dibromosalicylaldehyde was prepared according
to Elzbieta et al. (1964) . Two mole equivalents of 3,5-dibromosalicylaldehyde in ethanol (50 ml) was slowly added to 1,2-phenylenediamine (6 g) in ethanol (100 ml) with continuous stirring. The Schiff base molecule, viz. 4,4',6,6'-tetrabromo-2,2'-[1,2-phenylenebis(nitrilomethylidyne)] diphenol, precipitated immediately. In the second stage, the ligand (1 mmol), Cu(OAc) 2 (1 mmol) and DMF (25 ml) were refluxed for 1 h. The hot solution was filtered and allowed to stand at room temperature undisturbed for about three weeks, resulting in dark green crystals. ) and C-O distances in both disorder components were restrained to 1.460 (3), 1.340 (3) and 1.220 (3) Å, respectively. H atoms were positioned geometrically and refined using a riding model, with C-H = 0.95 or 0.98 Å and U iso (H) = 1.2U eq (C).
Figures Fig. 1 . A view of the title complex, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level. H atoms have been omitted for the sake of clarity. Both disorder components of the uncoordinated solvent molecule are shown.
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